Cargando…

Recent advances in the treatment of systemic sclerosis associated interstitial lung disease

Connective tissue diseases (CTDs) are a heterogenous group of systemic inflammatory disorders. The development of connective tissue disease-associated interstitial lung disease (CTD-ILD) is a key complication associated with significant morbidity and mortality. The aim of this review is to explore t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kamenova, Antoniya, Tzouvelekis, Argyris, Margaritopoulos, George A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10079888/ https://www.ncbi.nlm.nih.gov/pubmed/37035331 http://dx.doi.org/10.3389/fmed.2023.1155771

Ejemplares similares

Biologic Treatments in Interstitial Lung Diseases
por: Karampitsakos, Theodoros, et al.
Publicado: (2019)

Serum biomarkers in interstitial lung diseases
por: Tzouvelekis, Argyris, et al.
Publicado: (2005)

Effect and Safety of Mycophenolate Mofetil or Sodium in Systemic Sclerosis-Associated Interstitial Lung Disease: A Meta-Analysis
por: Tzouvelekis, Argyris, et al.
Publicado: (2012)

Recent Advances in the Treatment of Interstitial Lung Diseases
por: Bang, Aneesh A, et al.
Publicado: (2023)

Endotyping of progressive fibrotic interstitial lung diseases: It is the final destination that matters and not the journey
por: Tzouvelekis, Argyris, et al.
Publicado: (2020)

Bilateral mediastinal lymphadenopathy with cough and shortness of breath
por: Kamenova, Antoniya, et al.
Publicado: (2022)

Angiogenesis in Interstitial Lung Diseases: a pathogenetic hallmark or a bystander?
por: Tzouvelekis, Argyris, et al.
Publicado: (2006)

Recent Treatments of Interstitial Lung Disease with Systemic Sclerosis
por: Yasuoka, Hidekata
Publicado: (2016)

Lung Cancer and Interstitial Lung Diseases: A Systematic Review
por: Archontogeorgis, Kostas, et al.
Publicado: (2012)

Systemic Sclerosis Associated Interstitial Lung Disease: New Directions in Disease Management
por: Mirsaeidi, Mehdi, et al.
Publicado: (2019)

Editorial: Immune-mediated lung injury
por: Karampitsakos, Theodoros, et al.
Publicado: (2023)

Recent Advances in Predicting Mortality and Progression of Systemic Sclerosis–Associated Interstitial Lung Disease
por: Park, Moo Suk
Publicado: (2020)

Comorbidities in interstitial lung diseases
por: Margaritopoulos, George A., et al.
Publicado: (2017)

Clinical features and outcomes of patients with myositis associated-interstitial lung disease
por: Karampitsakos, Theodoros, et al.
Publicado: (2023)

Small airways dysfunction in patients with systemic sclerosis and interstitial lung disease
por: Panagopoulos, Panagiotis K., et al.
Publicado: (2022)

Interstitial lung disease
por: Antoniou, Katerina M., et al.
Publicado: (2014)

Epidemiology, Mortality and Healthcare Resource Utilization Associated With Systemic Sclerosis-Associated Interstitial Lung Disease in France
por: Cottin, Vincent, et al.
Publicado: (2021)

Smoking and interstitial lung diseases
por: Margaritopoulos, George A., et al.
Publicado: (2015)

The Role of Hydroxychloroquine in Coronavirus Disease 2019. A Versatile Tool at the Service of Humanity
por: Tzouvelekis, Argyris, et al.
Publicado: (2020)

Characteristics and risk factors of mortality in patients with systemic sclerosis-associated interstitial lung disease
por: Jang, Hye Jin, et al.
Publicado: (2023)

Automatic Quantification of Interstitial Lung Disease From Chest Computed Tomography in Systemic Sclerosis
por: Carvalho, Alysson Roncally S., et al.
Publicado: (2020)

Post-COVID-19 interstitial lung disease: Insights from a machine learning radiographic model
por: Karampitsakos, Theodoros, et al.
Publicado: (2023)

Systemic Sclerosis Associated Interstitial Lung Disease and Nintedanib: A Rare Disease and a Promising Drug
por: Kafle, Sunam, et al.
Publicado: (2021)

Corrigendum: Post-COVID-19 interstitial lung disease: Insights from a machine learning radiographic model
por: Karampitsakos, Theodoros, et al.
Publicado: (2023)

Computed Tomography Predictors of Mortality or Disease Progression in Systemic Sclerosis–Interstitial Lung Disease: A Systematic Review
por: Landini, Nicholas, et al.
Publicado: (2022)

IL-13 and IL-33 Serum Levels Are Increased in Systemic Sclerosis Patients With Interstitial Lung Disease
por: Versace, Antonio Giovanni, et al.
Publicado: (2022)

The Management of Patients With Idiopathic Pulmonary Fibrosis
por: Spagnolo, Paolo, et al.
Publicado: (2018)

Epidemiology of systemic sclerosis and systemic sclerosis-associated interstitial lung disease
por: Bergamasco, Aurore, et al.
Publicado: (2019)

Mechanisms of progressive fibrosis in connective tissue disease (CTD)-associated interstitial lung diseases (ILDs)
por: Spagnolo, Paolo, et al.
Publicado: (2021)

Editorial: Interstitial Lung Disease in the Context of Systemic Disease: Pathophysiology, Treatment and Outcomes
por: Korsten, Peter, et al.
Publicado: (2021)

Editorial: Multidisciplinary approach to interstitial lung disease associated with systemic rheumatic diseases
por: Sambataro, Gianluca, et al.
Publicado: (2022)

Pathogenesis of systemic sclerosis associated interstitial lung disease
por: Nihtyanova, Svetlana I, et al.
Publicado: (2020)

Methotrexate-Associated Pneumonitis and Rheumatoid Arthritis-Interstitial Lung Disease: Current Concepts for the Diagnosis and Treatment
por: Fragoulis, George E., et al.
Publicado: (2019)

Progressive interstitial lung disease in patients with systemic sclerosis-associated interstitial lung disease in the EUSTAR database
por: Hoffmann-Vold, Anna-Maria, et al.
Publicado: (2021)

Rituximab treatment in patients with systemic sclerosis and interstitial lung disease
por: Mohammed, Abdel Gaffar A., et al.
Publicado: (2017)

The role of antifibrotic therapies in the treatment of systemic sclerosis–associated interstitial lung disease
por: Boleto, Gonçalo, et al.
Publicado: (2022)

Interstitial lung disease pathology in systemic sclerosis
por: Konopka, Kristine E., et al.
Publicado: (2021)

Genetic Susceptibility to Interstitial Lung Disease Associated with Systemic Sclerosis
por: Tochimoto, Akiko, et al.
Publicado: (2016)

Interstitial lung disease associated with systemic sclerosis (SSc-ILD)
por: Cottin, Vincent, et al.
Publicado: (2019)

Resistin Expression Is Associated With Interstitial Lung Disease in Dermatomyositis
por: Ye, Lifang, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_nop4l3p0u1flh0kjkcr1l7v6pk